CheckMate 77 T: A phase 3 trial of neoadjuvant nivolumab (NIVO)-MedSci.cn

CheckMate 77 T: A phase 3 trial of neoadjuvant nivolumab (NIVO)

Schumann, C; Cascone, T; Provencio, M; Sepesi, B; Lu, S; Aanur, N; Li, S; Spicer, J

PNEUMOLOGIE, 2021; 75 (): S16